Tuesday, November 22, 2016

BRIEF-Allergan completes acquisition of Chase Pharmaceuticals

* Allergan acquires Chase Pharmaceuticals to expand CNS

research and development pipeline and build on commitment to

alzheimer's disease

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)